Trial Profile
Post-Marketing Surveillance of Micardis (Telmisartan) Special Drug Use-results Survey on Long-term Treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2014
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary)
- Indications Hypertension
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 22 Sep 2014 New trial record